Lily Kim Named as Mass High Tech Women to Watch Honoree

March 18, 2013

Hertz Fellow Lily Y. Kim, PhD, associate director of platform development, Wyss Institute/ Harvard

Lily Kim has provide sustained leadership in fluidic MEMS over the past several years. She now provides even wider technology development and commercialization leadership at the Wyss Institute where she is focused on technology translation and commercialization strategy.

Kim is considered the worldwide nexus point for microfluidics researchers, entrepreneurs, and acquirers. She created, maintains, and continues to grow the microfluidics community through FluidicMEMS (a blog + networking group) to support the cluster around commercialization of lab-on-a-chip technologies.


From MHT-Boston Business Journal

Patricia Resende, Managing Editor

Mass High Tech has named its 2013 Women to Watch honorees. Now in its 10th year, the annual Women to Watch program recognizes women in tech and life sciences who are thought leaders in their field and shaping the future of their industries for years to come. This year’s honorees were selected from more than 125 nominations.

"As more technology and life sciences companies continue to put amazingly bright and powerful women in more prominent roles, the Women to Watch awards continues to shine a much deserved spotlight on these women and continues to acknowledge them for their leadership behind the scenes in the office and in their community. This year’s honorees come from a broad range of sectors including clean tech, academia and biotech, showing the growth of women in leadership roles throughout many industries. Mass High Tech is proud to honor these women and looks forward to their continued success,” said Chris McIntosh, Publisher, Mass High Tech/Boston Business Journal.

The women will be honored at an event held Thursday, May 9 from 7:30 a.m. to 10:30 a.m. at the Westin Boston Waterfront Hotel, 425 Summer St. Boston.


2013 Women to Watch Honorees are:

Rebecca Smith Allen, CEO and Co-founder, Infrared5

Susan Bornstein, MPH, senior director of Information Strategy and Analytics, Clinical Informatics, Pfizer

MaryAlice Brady, CEO, MosaicHub

Suzanne L. Bruhn, Ph.D., president and CEO, Promedior

Sheila DeWitt, PhD, president and CEO, DeuteRx, LLC

Lital Asher-Dotan, open innovation manager, Global Business Development, P&G

Joanna Dowling, director, president and CFO, Custom Group Manufacturing Technology

Angelika Fretzen, VP of Pharmaceutical Chemistry and Development, Ironwood Pharmaceuticals

Dr. Gretchen Fougere, assistant dean of outreach and diversity, Boston University

Anne-Laure Grillot, Ph.D. , research fellow II, Chemistry, Vertex Pharmaceuticals

Susie Truong Harborth, chief financial officer, GnuBIO

Leslie Jelalian, vice president of Intelligence, Reconnaissance and Surveillance, BAE Systems

Lauren Kessler, principal member technical staff, Draper Laboratory

Lily Y. Kim, PhD, associate director of platform development, Wyss Institute/ Harvard University

Wendy Pryce Lewis, head of R&D, Cabot Aerogel, Cabot Corp.

Polina Raygorodskaya, CEO, Wanderu

Sara Spalding, senior director, Microsoft NERD Center

Amy Winslow, president, Magellan Diagnostics

Anita Worden, chairwoman, Solectria Renewables LLC

Holly Yanco, professor, UMass Lowell